Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$183.71 - $210.25 $1,469 - $1,682
8 New
8 $2,000
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $408,049 - $578,289
-1,597 Closed
0 $0
Q4 2021

Mar 14, 2022

SELL
$351.38 - $448.68 $116,658 - $148,961
-332 Reduced 17.21%
1,597 $796,000
Q3 2021

Mar 07, 2022

BUY
$372.64 - $458.3 $718,822 - $884,060
1,929 New
1,929 $796,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Psagot Value Holdings Ltd. Portfolio

Follow Psagot Value Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

News

Stay updated on Psagot Value Holdings Ltd. with notifications on news.